{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:36:04Z","timestamp":1784640964802,"version":"3.55.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH grants GM 00451, CA 08676, and AM-16739"],"award-info":[{"award-number":["NIH grants GM 00451, CA 08676, and AM-16739"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s11064-015-1678-y","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T15:02:35Z","timestamp":1438182155000},"page":"16-32","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Biochemical, Metabolic, and Behavioral Characteristics of Immature Chronic Hyperphenylalanemic Rats"],"prefix":"10.1007","volume":"41","author":[{"given":"Gerald A.","family":"Dienel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy F.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,30]]},"reference":[{"key":"1678_CR1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/GIM.0b013e3182141b48","volume":"13","author":"JJ Mitchell","year":"2011","unstructured":"Mitchell JJ, Trakadis YJ, Scriver CR (2011) Phenylalanine hydroxylase deficiency. Genet Med 13:697\u2013707","journal-title":"Genet Med"},{"key":"1678_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev.ge.28.120194.001041","volume":"28","author":"CR Scriver","year":"1994","unstructured":"Scriver CR, Eisensmith RC, Woo SL, Kaufman S (1994) The hyperphenylalaninemias of man and mouse. Annu Rev Genet 28:141\u2013165","journal-title":"Annu Rev Genet"},{"key":"1678_CR3","first-page":"266","volume-title":"The metabolic basis of inherited disease","author":"WE Knox","year":"1972","unstructured":"Knox WE (1972) Phenylketonuria. In: Stanbury JB, Wyngaarden JB, Fredrickson DS (eds) The metabolic basis of inherited disease, 3rd edn. McGraw-Hill, New York, pp 266\u2013295","edition":"3"},{"key":"1678_CR4","first-page":"270","volume-title":"The metabolic basis of inherited disease","author":"A Tourian","year":"1983","unstructured":"Tourian A, Sidbury JB (1983) Phenylketonuria and hyperphenylalanemia. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease, 5th edn. McGraw-Hill, New York, pp 270\u2013286","edition":"5"},{"key":"1678_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ymgme.2014.02.013","volume":"112","author":"KM Camp","year":"2014","unstructured":"Camp KM, Parisi MA, Acosta PB, Berry GT, Bilder DA, Blau N, Bodamer OA, Brosco JP, Brown CS, Burlina AB, Burton BK, Chang CS, Coates PM, Cunningham AC, Dobrowolski SF, Ferguson JH, Franklin TD, Frazier DM, Grange DK, Greene CL, Groft SC, Harding CO, Howell RR, Huntington KL, Hyatt-Knorr HD, Jevaji IP, Levy HL, Lichter-Konecki U, Lindegren ML, Lloyd-Puryear MA, Matalon K, MacDonald A, McPheeters ML, Mitchell JJ, Mofidi S, Moseley KD, Mueller CM, Mulberg AE, Nerurkar LS, Ogata BN, Pariser AR, Prasad S, Pridjian G, Rasmussen SA, Reddy UM, Rohr FJ, Singh RH, Sirrs SM, Stremer SE, Tagle DA, Thompson SM, Urv TK, Utz JR, van Spronsen F, Vockley J, Waisbren SE, Weglicki LS, White DA, Whitley CB, Wilfond BS, Yannicelli S, Young JM (2014) Phenylketonuria scientific review conference: state of the science and future research needs. Mol Genet Metab 112:87\u2013122","journal-title":"Mol Genet Metab"},{"key":"1678_CR6","first-page":"77","volume-title":"Aromatic amino acid hydroxylases and mental disease","author":"K Blau","year":"1979","unstructured":"Blau K (1979) Phenylalanine hydroxylase deficiency: biochemical, physiological, and clinical aspects of phenylketonuria and related phenylalaninemias. In: Youdim MBH (ed) Aromatic amino acid hydroxylases and mental disease. John Wiley & Sons, Chichester, pp 77\u2013139"},{"key":"1678_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4615-8237-3_1","volume-title":"Advances in neurochemistry","author":"S Kaufman","year":"1977","unstructured":"Kaufman S (1977) Phenylketonuria: biochemical mechanisms. In: Agranoff BW, Aprison MH (eds) Advances in neurochemistry. Plenum Press, New York, pp 1\u2013132"},{"key":"1678_CR8","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0022-3476(89)80161-1","volume":"114","author":"S Kaufman","year":"1989","unstructured":"Kaufman S (1989) An evaluation of the possible neurotoxicity of metabolites of phenylalanine. J Pediatr 114:895\u2013900","journal-title":"J Pediatr"},{"key":"1678_CR9","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1111\/j.1471-4159.1985.tb07232.x","volume":"45","author":"YH Loo","year":"1985","unstructured":"Loo YH, Potempska A, Wisniewski HM (1985) A biochemical explanation of phenyl acetate neurotoxicity in experimental phenylketonuria. J Neurochem 45:1596\u20131600","journal-title":"J Neurochem"},{"key":"1678_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/ana.410070609","volume":"7","author":"GY Wen","year":"1980","unstructured":"Wen GY, Wisniewski HM, Shek JW, Loo YH, Fulton TR (1980) Neuropathology of phenylacetate poisoning in rats: an experimental model of phenylketonuria. Ann Neurol 7:557\u2013566","journal-title":"Ann Neurol"},{"key":"1678_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1139\/o69-044","volume":"47","author":"JT Clarke","year":"1969","unstructured":"Clarke JT, Lowden JA (1969) Hyperphenylalaninemia: effect on the developing rat brain. Can J Biochem 47:291\u2013295","journal-title":"Can J Biochem"},{"key":"1678_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1042\/bj1700449b","volume":"170","author":"JA Delvalle","year":"1978","unstructured":"Delvalle JA, Dienel G, Greengard O (1978) Comparison of alpha-methylphenylalanine and p-chlorophenylalanine as inducers of chronic hyperphenylalaninaemia in developing rats. Biochem J 170:449\u2013459","journal-title":"Biochem J"},{"key":"1678_CR13","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/genetics\/134.4.1205","volume":"134","author":"A Shedlovsky","year":"1993","unstructured":"Shedlovsky A, McDonald JD, Symula D, Dove WF (1993) Mouse models of human phenylketonuria. Genetics 134:1205\u20131210","journal-title":"Genetics"},{"key":"1678_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/0304-4165(80)90316-5","volume":"627","author":"JD Lane","year":"1980","unstructured":"Lane JD, Schone B, Langenbeck U, Neuhoff V (1980) Characterization of experimental phenylketonuria. Augmentation of hyperphenylalaninemia with alpha-methylphenylalanine and p-chlorophenylalanine. Biochim Biophys Acta 627:144\u2013156","journal-title":"Biochim Biophys Acta"},{"key":"1678_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/B978-0-12-395625-5.50008-X","volume-title":"Metabolic inhibitors A comprehensive treatise","author":"EG McGeer","year":"1973","unstructured":"McGeer EG, McGeer PL (1973) Amino acid hydroxylase inhibitors. In: Hochster RM, Kates M, Quastel JH (eds) Metabolic inhibitors A comprehensive treatise. Academic Press, New York, pp 45\u2013105"},{"key":"1678_CR16","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/0006-2952(65)90103-6","volume":"14","author":"S Udenfriend","year":"1965","unstructured":"Udenfriend S, Zaltzman-Nirenberg P, Nagatsu T (1965) Inhibitors of purified beef adrenal tyrosine hydroxylase. Biochem Pharmacol 14:837\u2013845","journal-title":"Biochem Pharmacol"},{"key":"1678_CR17","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1096-7192(02)00115-4","volume":"76","author":"JD McDonald","year":"2002","unstructured":"McDonald JD, Andriolo M, Cali F, Mirisola M, Puglisi-Allegra S, Romano V, Sarkissian CN, Smith CB (2002) The phenylketonuria mouse model: a meeting review. Mol Genet Metab 76:256\u2013261","journal-title":"Mol Genet Metab"},{"key":"1678_CR18","unstructured":"Dienel GA (1977) Brain development in normal and chronic hyperphenylalanemic rats. PhD thesis, Department of Biological Chemistry, Harvard University"},{"key":"1678_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1471-4159.1981.tb02374.x","volume":"36","author":"GA Dienel","year":"1981","unstructured":"Dienel GA (1981) Chronic hyperphenylalaninemia produces cerebral hyperglycinemia in immature rats. J Neurochem 36:34\u201343","journal-title":"J Neurochem"},{"key":"1678_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0003-2697(65)90196-X","volume":"13","author":"JV Benson Jr","year":"1965","unstructured":"Benson JV Jr, Patterson JA (1965) Accelerated chromatographic analysis of amino acids commonly found in physiological fluids on a spherical resin of specific design. Anal Biochem 13:265\u2013280","journal-title":"Anal Biochem"},{"key":"1678_CR21","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1042\/bj0470605","volume":"47","author":"HA Krebs","year":"1950","unstructured":"Krebs HA (1950) Manometric determination of l-aspartic acid and l-asparagine. Biochem J 47:605\u2013614","journal-title":"Biochem J"},{"key":"1678_CR22","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/0024-3205(66)90116-0","volume":"5","author":"FN Minard","year":"1966","unstructured":"Minard FN, Mushahwar IK (1966) Synthesis of gamma-aminobutyric acid from a pool of glutamic acid in brain after decapitation. Life Sci 5:1409\u20131413","journal-title":"Life Sci"},{"key":"1678_CR23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1139\/o70-042","volume":"48","author":"Y Yoshino","year":"1970","unstructured":"Yoshino Y, Elliott KA (1970) Incorporation of carbon atoms from glucose into free amino acids in brain under normal and altered conditions. Can J Biochem 48:228\u2013235","journal-title":"Can J Biochem"},{"key":"1678_CR24","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/j.1471-4159.1977.tb10649.x","volume":"28","author":"L Sokoloff","year":"1977","unstructured":"Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M (1977) The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28:897\u2013916","journal-title":"J Neurochem"},{"key":"1678_CR25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/jcbfm.1983.46","volume":"3","author":"NF Cruz","year":"1983","unstructured":"Cruz NF, Duffy TE (1983) Local cerebral glucose metabolism in rats with chronic portacaval shunts. J Cereb Blood Flow Metab 3:311\u2013320","journal-title":"J Cereb Blood Flow Metab"},{"key":"1678_CR26","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0531-5565(78)90049-9","volume":"13","author":"J Miquel","year":"1978","unstructured":"Miquel J, Blasco M (1978) A simple technique for evaluation of vitality loss in aging mice, by testing their muscular coordination and vigor. Exp Gerontol 13:389\u2013396","journal-title":"Exp Gerontol"},{"key":"1678_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0091-3057(81)90236-7","volume":"14","author":"LL Barclay","year":"1981","unstructured":"Barclay LL, Gibson GE, Blass JP (1981) The string test: an early behavioral change in thiamine deficiency. Pharmacol Biochem Behav 14:153\u2013157","journal-title":"Pharmacol Biochem Behav"},{"key":"1678_CR28","volume-title":"Fluorescence assays in biology and medicine","author":"S Udenfriend","year":"1962","unstructured":"Udenfriend S (1962) Fluorescence assays in biology and medicine. Academic Press, New York"},{"key":"1678_CR29","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/clinchem\/10.12.1098","volume":"10","author":"PW Wong","year":"1964","unstructured":"Wong PW, O\u2019Flynn ME, Inouye T (1964) Micromethods for measuring phenylalanine and tyrosine in serum. Clin Chem 10:1098\u20131104","journal-title":"Clin Chem"},{"key":"1678_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1017\/S0033291700013830","volume":"6","author":"PM Daniel","year":"1976","unstructured":"Daniel PM, Moorhouse SR, Pratt OE (1976) Amino acid precursors of monoamine neurotransmitters and some factors influencing their supply to the brain. Psychol Med 6:277\u2013286","journal-title":"Psychol Med"},{"key":"1678_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1471-4159.1977.tb07714.x","volume":"28","author":"WM Pardridge","year":"1977","unstructured":"Pardridge WM (1977) Kinetics of competitive inhibition of neutral amino acid transport across the blood\u2013brain barrier. J Neurochem 28:103\u2013108","journal-title":"J Neurochem"},{"key":"1678_CR32","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1006\/jmrb.1995.1084","volume":"107","author":"R Kreis","year":"1995","unstructured":"Kreis R, Pietz J, Penzien J, Herschkowitz N, Boesch C (1995) Identification and quantitation of phenylalanine in the brain of patients with phenylketonuria by means of localized in vivo 1H magnetic-resonance spectroscopy. J Magn Reson B 107:242\u2013251","journal-title":"J Magn Reson B"},{"key":"1678_CR33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1203\/00006450-199502000-00020","volume":"37","author":"EJ Novotny Jr","year":"1995","unstructured":"Novotny EJ Jr, Avison MJ, Herschkowitz N, Petroff OA, Prichard JW, Seashore MR, Rothman DL (1995) In vivo measurement of phenylalanine in human brain by proton nuclear magnetic resonance spectroscopy. Pediatr Res 37:244\u2013249","journal-title":"Pediatr Res"},{"key":"1678_CR34","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1023\/A:1005621727560","volume":"23","author":"V Leuzzi","year":"2000","unstructured":"Leuzzi V, Bianchi MC, Tosetti M, Carducci CL, Carducci CA, Antonozzi I (2000) Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria. J Inherit Metab Dis 23:563\u2013570","journal-title":"J Inherit Metab Dis"},{"key":"1678_CR35","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1542\/peds.112.S4.1575","volume":"112","author":"RA Moats","year":"2003","unstructured":"Moats RA, Moseley KD, Koch R, Nelson M Jr (2003) Brain phenylalanine concentrations in phenylketonuria: research and treatment of adults. Pediatrics 112:1575\u20131579","journal-title":"Pediatrics"},{"issue":"Suppl 2","key":"1678_CR36","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1007\/PL00014374","volume":"159","author":"HE Moller","year":"2000","unstructured":"Moller HE, Ullrich K, Weglage J (2000) In vivo proton magnetic resonance spectroscopy in phenylketonuria. Eur J Pediatr 159(Suppl 2):S121\u2013S125","journal-title":"Eur J Pediatr"},{"key":"1678_CR37","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/00004647-200103000-00011","volume":"21","author":"A Rupp","year":"2001","unstructured":"Rupp A, Kreis R, Zschocke J, Slotboom J, Boesch C, Rating D, Pietz J (2001) Variability of blood\u2013brain ratios of phenylalanine in typical patients with phenylketonuria. J Cereb Blood Flow Metab 21:276\u2013284","journal-title":"J Cereb Blood Flow Metab"},{"key":"1678_CR38","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1203\/01.PDR.0000055867.83310.9E","volume":"53","author":"J Pietz","year":"2003","unstructured":"Pietz J, Rupp A, Ebinger F, Rating D, Mayatepek E, Boesch C, Kreis R (2003) Cerebral energy metabolism in phenylketonuria: findings by quantitative in vivo 31P MR spectroscopy. Pediatr Res 53:654\u2013662","journal-title":"Pediatr Res"},{"key":"1678_CR39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1096-7192(03)00078-7","volume":"79","author":"R Koch","year":"2003","unstructured":"Koch R, Moseley KD, Yano S, Nelson M Jr, Moats RA (2003) Large neutral amino acid therapy and phenylketonuria: a promising approach to treatment. Mol Genet Metab 79:110\u2013113","journal-title":"Mol Genet Metab"},{"key":"1678_CR40","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1172\/JCI5017","volume":"103","author":"J Pietz","year":"1999","unstructured":"Pietz J, Kreis R, Rupp A, Mayatepek E, Rating D, Boesch C, Bremer HJ (1999) Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria. J Clin Invest 103:1169\u20131178","journal-title":"J Clin Investig"},{"key":"1678_CR41","first-page":"223","volume":"17","author":"K Adriaenssens","year":"1969","unstructured":"Adriaenssens K, Allen RJ, Lowenthal A, Mardens Y, Tourtellotte WW (1969) Brain and cerebrospinal fluid free amino acids in phenylketonuria. J Genet Hum 17:223\u2013230","journal-title":"J Genet Hum"},{"key":"1678_CR42","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1056\/NEJM197012172832503","volume":"283","author":"CM McKean","year":"1970","unstructured":"McKean CM, Peterson NA (1970) Glutamine in the phenylketonuric central nervous system. N Engl J Med 283:1364\u20131367","journal-title":"N Engl J Med"},{"key":"1678_CR43","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1126\/science.179.4076.904","volume":"179","author":"AL Miller","year":"1973","unstructured":"Miller AL, Hawkins RA, Veech RL (1973) Phenylketonuria: phenylalanine inhibits brain pyruvate kinase in vivo. Science 179:904\u2013906","journal-title":"Science"},{"key":"1678_CR44","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1042\/bj1280677","volume":"128","author":"MS Patel","year":"1972","unstructured":"Patel MS (1972) The effect of phenylpyruvate on pyruvate metabolism in rat brain. Biochem J 128:677\u2013684","journal-title":"Biochem J"},{"key":"1678_CR45","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1471-4159.1976.tb04458.x","volume":"26","author":"JM Land","year":"1976","unstructured":"Land JM, Mowbray J, Clark JB (1976) Control of pyruvate and beta-hydroxybutyrate utilization in rat brain mitochondria and its relevance to phenylketonuria and maple syrup urine disease. J Neurochem 26:823\u2013830","journal-title":"J Neurochem"},{"key":"1678_CR46","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1203\/00006450-197107000-00005","volume":"5","author":"S Castells","year":"1971","unstructured":"Castells S, Zischka R, Addo N (1971) Alternation in composition of deoxyribonucleic acid, ribonucleic acid, proteins, and amino acids in brain of rats fed high and low phenylalanine diets. Pediatr Res 5:329\u2013334","journal-title":"Pediatr Res"},{"key":"1678_CR47","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/j.1469-8749.1966.tb01832.x","volume":"8","author":"D O\u2019Brien","year":"1966","unstructured":"O\u2019Brien D, Ibbot FA (1966) Effect of prolonged phenylalanine loading on the free amino-acid and lipid content of the infant monkey brain. Dev Med Child Neurol 8:724\u2013728","journal-title":"Dev Med Child Neurol"},{"issue":"Suppl","key":"1678_CR48","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/j.ymgme.2013.08.004","volume":"110","author":"KR Vogel","year":"2013","unstructured":"Vogel KR, Arning E, Wasek BL, Bottiglieri T, Gibson KM (2013) Characterization of 2-(methylamino)alkanoic acid capacity to restrict blood\u2013brain phenylalanine transport in Pah enu2 mice: preliminary findings. Mol Genet Metab 110(Suppl):S71\u2013S78","journal-title":"Mol Genet Metab"},{"key":"1678_CR49","first-page":"21","volume":"98","author":"E Arning","year":"2009","unstructured":"Arning E, Bottiglieri T, Sun Q, Jansen EEW, Jakobs C, Lin B, Stetson L, Harding CO, Gibson KM (2009) Metabolic profiling in phenylalanine hydroxylase deficient (PAH \u2212\/\u2212) mouse brain reveals decreased amino acid neurotransmitters and preferential alterations of the serotonergic system. Mol Genet Metab 98:21","journal-title":"Mol Genet Metab"},{"key":"1678_CR50","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1056\/NEJM197506122922404","volume":"292","author":"TL Perry","year":"1975","unstructured":"Perry TL, Urquhart N, MacLean J, Evans ME, Hansen S, Davidson GF, Applegarth DA, MacLeod PJ, Lock JE (1975) Nonketotic hyperglycinemia. Glycine accumulation due to absence of glycerine cleavage in brain. N Engl J Med 292:1269\u20131273","journal-title":"N Engl J Med"},{"key":"1678_CR51","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1023\/B:BOLI.0000031222.38328.59","volume":"27","author":"DA Applegarth","year":"2004","unstructured":"Applegarth DA, Toone JR (2004) Glycine encephalopathy (nonketotic hyperglycinaemia): review and update. J Inherit Metab Dis 27:417\u2013422","journal-title":"J Inherit Metab Dis"},{"key":"1678_CR52","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2183\/pjab.84.246","volume":"84","author":"G Kikuchi","year":"2008","unstructured":"Kikuchi G, Motokawa Y, Yoshida T, Hiraga K (2008) Glycine cleavage system: reaction mechanism, physiological significance, and hyperglycinemia. Proc Jpn Acad Ser B Phys Biol Sci 84:246\u2013263","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"1678_CR53","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/mrm.24368","volume":"68","author":"A Banerjee","year":"2012","unstructured":"Banerjee A, Ganji S, Hulsey K, Dimitrov I, Maher E, Ghose S, Tamminga C, Choi C (2012) Measurement of glycine in gray and white matter in the human brain in vivo by 1H MRS at 7.0 T. Magn Reson Med 68:325\u2013331","journal-title":"Magn Reson Med"},{"key":"1678_CR54","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ymgme.2007.02.002","volume":"91","author":"S Schindeler","year":"2007","unstructured":"Schindeler S, Ghosh-Jerath S, Thompson S, Rocca A, Joy P, Kemp A, Rae C, Green K, Wilcken B, Christodoulou J (2007) The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Mol Genet Metab 91:48\u201354","journal-title":"Mol Genet Metab"},{"key":"1678_CR55","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/0003-9861(79)90535-6","volume":"198","author":"H Kochi","year":"1979","unstructured":"Kochi H, Hayasaka K, Hiraga K, Kikuchi G (1979) Reduction of the level of the glycine cleavage system in the rat liver resulting from administration of dipropylacetic acid: an experimental approach to hyperglycinemia. Arch Biochem Biophys 198:589\u2013597","journal-title":"Arch Biochem Biophys"},{"key":"1678_CR56","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1528-1157.1980.tb04310.x","volume":"21","author":"PB Mortensen","year":"1980","unstructured":"Mortensen PB, Kolvraa S, Christensen E (1980) Inhibition of the glycine cleavage system: hyperglycinemia and hyperglycinuria caused by valproic acid. Epilepsia 21:563\u2013569","journal-title":"Epilepsia"},{"key":"1678_CR57","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1016\/0006-2952(85)90010-3","volume":"34","author":"A Martin-Gallardo","year":"1985","unstructured":"Martin-Gallardo A, Rodriguez P, Lopez M, Benavides J, Ugarte M (1985) Effects of dipropylacetate on the glycine cleavage enzyme system and glycine levels. A possible experimental approach to non-ketotic hyperglycinemia. Biochem Pharmacol 34:2877\u20132882","journal-title":"Biochem Pharmacol"},{"key":"1678_CR58","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1055\/s-0028-1085322","volume":"10","author":"S Simila","year":"1979","unstructured":"Simila S, von Wendt L, Linna SL, Saukkonen AL, Huhtaniemi I (1979) Dipropylacetate and hyperglycinemia. Neuropadiatrie 10:158\u2013160","journal-title":"Neuropadiatrie"},{"key":"1678_CR59","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1177\/0883073811402204","volume":"26","author":"R Dhamija","year":"2011","unstructured":"Dhamija R, Gavrilova RH, Wirrell EC (2011) Valproate-induced worsening of seizures: clue to underlying diagnosis. J Child Neurol 26:1319\u20131321","journal-title":"J Child Neurol"},{"key":"1678_CR60","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4103\/1817-1745.159200","volume":"10","author":"V Subramanian","year":"2015","unstructured":"Subramanian V, Kadiyala P, Hariharan P, Neeraj E (2015) A rare case of glycine encephalopathy unveiled by valproate therapy. J Pediatr Neurosci 10:143\u2013145","journal-title":"J Pediatr Neurosci"},{"key":"1678_CR61","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0003-9861(86)90002-0","volume":"249","author":"H Kochi","year":"1986","unstructured":"Kochi H, Seino H, Ono K (1986) Inhibition of glycine oxidation by pyruvate, alpha-ketoglutarate, and branched-chain alpha-keto acids in rat liver mitochondria: presence of interaction between the glycine cleavage system and alpha-keto acid dehydrogenase complexes. Arch Biochem Biophys 249:263\u2013272","journal-title":"Arch Biochem Biophys"},{"key":"1678_CR62","doi-asserted-by":"publisher","first-page":"11014","DOI":"10.1073\/pnas.97.20.11014","volume":"97","author":"CB Smith","year":"2000","unstructured":"Smith CB, Kang J (2000) Cerebral protein synthesis in a genetic mouse model of phenylketonuria. Proc Natl Acad Sci USA 97:11014\u201311019","journal-title":"Proc Natl Acad Sci USA"},{"key":"1678_CR63","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s10545-007-0583-1","volume":"30","author":"M Qin","year":"2007","unstructured":"Qin M, Smith CB (2007) Regionally selective decreases in cerebral glucose metabolism in a mouse model of phenylketonuria. J Inherit Metab Dis 30:318\u2013325","journal-title":"J Inherit Metab Dis"},{"key":"1678_CR64","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000111840","volume":"12","author":"R Burri","year":"1990","unstructured":"Burri R, Matthieu JM, Vandevelde M, Lazeyras F, Posse S, Herschkowitz N (1990) Brain damage and recovery in hyperphenylalaninemic rats. Dev Neurosci 12:116\u2013125","journal-title":"Dev Neurosci"},{"key":"1678_CR65","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1023\/A:1021986820562","volume":"18","author":"G Lutz Mda","year":"2003","unstructured":"Lutz Mda G, Feksa LR, Wyse AT, Dutra-Filho CS, Wajner M, Wannmacher CM (2003) Alanine prevents the in vitro inhibition of glycolysis caused by phenylalanine in brain cortex of rats. Metab Brain Dis 18:87\u201394","journal-title":"Metab Brain Dis"},{"key":"1678_CR66","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1111\/j.1528-1167.2007.01115.x","volume":"48","author":"AE Martynyuk","year":"2007","unstructured":"Martynyuk AE, Ucar DA, Yang DD, Norman WM, Carney PR, Dennis DM, Laipis PJ (2007) Epilepsy in phenylketonuria: a complex dependence on serum phenylalanine levels. Epilepsia 48:1143\u20131150","journal-title":"Epilepsia"},{"key":"1678_CR67","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1203\/00006450-199607000-00004","volume":"40","author":"S Hasselbalch","year":"1996","unstructured":"Hasselbalch S, Knudsen GM, Toft PB, Hogh P, Tedeschi E, Holm S, Videbaek C, Henriksen O, Lou HC, Paulson OB (1996) Cerebral glucose metabolism is decreased in white matter changes in patients with phenylketonuria. Pediatr Res 40:21\u201324","journal-title":"Pediatr Res"},{"key":"1678_CR68","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/BF00256553","volume":"13","author":"K Yanai","year":"1987","unstructured":"Yanai K, Iinuma K, Matsuzawa T, Ito M, Miyabayashi S, Narisawa K, Ido T, Yamada K, Tada K (1987) Cerebral glucose utilization in pediatric neurological disorders determined by positron emission tomography. Eur J Nucl Med 13:292\u2013296","journal-title":"Eur J Nucl Med"},{"key":"1678_CR69","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3988\/jcn.2013.9.3.151","volume":"9","author":"C Ficicioglu","year":"2013","unstructured":"Ficicioglu C, Dubroff JG, Thomas N, Gallagher PR, Burfield J, Hussa C, Randall R, Zhuang H (2013) A pilot study of fluorodeoxyglucose positron emission tomography findings in patients with phenylketonuria before and during sapropterin supplementation. J Clin Neurol 9:151\u2013156","journal-title":"J Clin Neurol"},{"key":"1678_CR70","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/BF01054531","volume":"67","author":"JD Lane","year":"1980","unstructured":"Lane JD, Neuhoff V (1980) Phenylketonuria: clinical and experimental considerations revealed by the use of animal models. Naturwissenschaften 67:227\u2013233","journal-title":"Naturwissenschaften"},{"key":"1678_CR71","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1111\/j.1471-4159.1981.tb00589.x","volume":"36","author":"PA Binek","year":"1981","unstructured":"Binek PA, Johnson TC, Kelly CJ (1981) Effect of alpha-methylphenylalanine and phenylalanine on brain polyribosomes and protein synthesis. J Neurochem 36:1476\u20131484","journal-title":"J Neurochem"},{"key":"1678_CR72","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0014-4886(80)90232-0","volume":"67","author":"DA Figlewicz","year":"1980","unstructured":"Figlewicz DA, Druse MJ (1980) Experimental hyperphenylalaninemia: effect on central nervous system myelin subfractions. Exp Neurol 67:315\u2013329","journal-title":"Exp Neurol"},{"key":"1678_CR73","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/BF00964709","volume":"5","author":"RC Johnson","year":"1980","unstructured":"Johnson RC, Shah SN (1980) Effects of alpha-methylphenylalanine plus phenylalanine treatment during development on myelin in rat brain. Neurochem Res 5:709\u2013718","journal-title":"Neurochem Res"},{"key":"1678_CR74","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0091-3057(79)90031-5","volume":"11","author":"MW Luttges","year":"1979","unstructured":"Luttges MW, Gerren RA (1979) Postnatal alpha-methylphenylalanine treatment effects on adult mouse locomotor activity and avoidance learning. Pharmacol Biochem Behav 11:493\u2013498","journal-title":"Pharmacol Biochem Behav"},{"key":"1678_CR75","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0006-8993(79)90507-9","volume":"179","author":"MP Nigam","year":"1979","unstructured":"Nigam MP, Labar DR (1979) The effect of hyperphenylalaninemia on size and density of synapses in rat neocortex. Brain Res 179:195\u2013198","journal-title":"Brain Res"},{"key":"1678_CR76","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1523\/JNEUROSCI.14-05-03072.1994","volume":"14","author":"A Diamond","year":"1994","unstructured":"Diamond A, Ciaramitaro V, Donner E, Djali S, Robinson MB (1994) An animal model of early-treated PKU. J Neurosci 14:3072\u20133082","journal-title":"J Neurosci"},{"key":"1678_CR77","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1471-4159.1961.tb13532.x","volume":"8","author":"TL Sourkes","year":"1961","unstructured":"Sourkes TL, Murphy GF, Chavez B, Zielinska M (1961) The action of some alpha-methyl and other amino acids on cerebral catecholamines. J Neurochem 8:109\u2013115","journal-title":"J Neurochem"},{"key":"1678_CR78","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/0006-2952(70)90148-6","volume":"19","author":"ML Torchiana","year":"1970","unstructured":"Torchiana ML, Porter CC, Stone CA, Hanson HM (1970) Some biochemical and pharmacological actions of-methylphenylalanine. Biochem Pharmacol 19:1601\u20131614","journal-title":"Biochem Pharmacol"},{"key":"1678_CR79","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s11011-013-9389-z","volume":"28","author":"EA Dos Reis","year":"2013","unstructured":"Dos Reis EA, Rieger E, de Souza SS, Rasia-Filho AA, Wannmacher CM (2013) Effects of a co-treatment with pyruvate and creatine on dendritic spines in rat hippocampus and posterodorsal medial amygdala in a phenylketonuria animal model. Metab Brain Dis 28:509\u2013517","journal-title":"Metab Brain Dis"},{"key":"1678_CR80","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/15419060802014222","volume":"15","author":"DA Iacobas","year":"2008","unstructured":"Iacobas DA, Iacobas S, Urban-Maldonado M, Scemes E, Spray DC (2008) Similar transcriptomic alterations in Cx43 knockdown and knockout astrocytes. Cell Commun Adhes 15:195\u2013206","journal-title":"Cell Commun Adhes"},{"key":"1678_CR81","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bbamem.2004.12.002","volume":"1711","author":"DA Iacobas","year":"2005","unstructured":"Iacobas DA, Iacobas S, Urban-Maldonado M, Spray DC (2005) Sensitivity of the brain transcriptome to connexin ablation. Biochim Biophys Acta 1711:183\u2013196","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl 2","key":"1678_CR82","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1007\/PL00014370","volume":"159","author":"R Surtees","year":"2000","unstructured":"Surtees R, Blau N (2000) The neurochemistry of phenylketonuria. Eur J Pediatr 159(Suppl 2):S109\u2013S113","journal-title":"Eur J Pediatr"},{"key":"1678_CR83","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s10571-011-9693-2","volume":"31","author":"GS Ribas","year":"2011","unstructured":"Ribas GS, Sitta A, Wajner M, Vargas CR (2011) Oxidative stress in phenylketonuria: What is the evidence? Cell Mol Neurobiol 31:653\u2013662","journal-title":"Cell Mol Neurobiol"},{"issue":"Suppl 1","key":"1678_CR84","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/j.ymgme.2009.10.016","volume":"99","author":"MJ de Groot","year":"2010","unstructured":"de Groot MJ, Hoeksma M, Blau N, Reijngoud DJ, van Spronsen FJ (2010) Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses. Mol Genet Metab 99(Suppl 1):S86\u2013S89","journal-title":"Mol Genet Metab"},{"issue":"Suppl 1","key":"1678_CR85","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1016\/j.ymgme.2009.10.181","volume":"99","author":"AE Martynyuk","year":"2010","unstructured":"Martynyuk AE, van Spronsen FJ, Van der Zee EA (2010) Animal models of brain dysfunction in phenylketonuria. Mol Genet Metab 99(Suppl 1):S100\u2013S105","journal-title":"Mol Genet Metab"},{"key":"1678_CR86","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10545-008-0917-7","volume":"32","author":"CN Sarkissian","year":"2009","unstructured":"Sarkissian CN, Gamez A, Scriver CR (2009) What we know that could influence future treatment of phenylketonuria. J Inherit Metab Dis 32:3\u20139","journal-title":"J Inherit Metab Dis"},{"key":"1678_CR87","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s10545-008-0946-2","volume":"32","author":"FJ van Spronsen","year":"2009","unstructured":"van Spronsen FJ, Hoeksma M, Reijngoud DJ (2009) Brain dysfunction in phenylketonuria: Is phenylalanine toxicity the only possible cause? J Inherit Metab Dis 32:46\u201351","journal-title":"J Inherit Metab Dis"},{"key":"1678_CR88","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11010-014-2118-z","volume":"395","author":"AP Moura","year":"2014","unstructured":"Moura AP, Grings M, Marcowich GF, Bumbel AP, Parmeggiani B, de Moura Alvorcem L, Wajner M, Leipnitz G (2014) Evidence that glycine induces lipid peroxidation and decreases glutathione concentrations in rat cerebellum. Mol Cell Biochem 395:125\u2013134","journal-title":"Mol Cell Biochem"},{"key":"1678_CR89","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s12640-013-9396-1","volume":"24","author":"AP Moura","year":"2013","unstructured":"Moura AP, Grings M, Dos Santos Parmeggiani B, Marcowich GF, Tonin AM, Viegas CM, Zanatta A, Ribeiro CA, Wajner M, Leipnitz G (2013) Glycine intracerebroventricular administration disrupts mitochondrial energy homeostasis in cerebral cortex and striatum of young rats. Neurotox Res 24:502\u2013511","journal-title":"Neurotox Res"},{"key":"1678_CR90","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.lfs.2011.06.013","volume":"89","author":"B Seminotti","year":"2011","unstructured":"Seminotti B, Knebel LA, Fernandes CG, Amaral AU, da Rosa MS, Eichler P, Leipnitz G, Wajner M (2011) Glycine intrastriatal administration induces lipid and protein oxidative damage and alters the enzymatic antioxidant defenses in rat brain. Life Sci 89:276\u2013281","journal-title":"Life Sci"},{"key":"1678_CR91","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.neuint.2010.04.002","volume":"56","author":"ENB Busanello","year":"2010","unstructured":"Busanello ENB, Moura AP, Viegas CM, Zanatta \u00c2, da Costa Ferreira G, Schuck PF, Wajner M (2010) Neurochemical evidence that glycine induces bioenergetical dysfunction. Neurochem Int 56:948\u2013954","journal-title":"Neurochem Int"},{"key":"1678_CR92","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1523\/JNEUROSCI.18-14-05225.1998","volume":"18","author":"RA Waniewski","year":"1998","unstructured":"Waniewski RA, Martin DL (1998) Preferential utilization of acetate by astrocytes is attributable to transport. J Neurosci 18:5225\u20135233","journal-title":"J Neurosci"},{"key":"1678_CR93","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/0006-8993(85)90552-9","volume":"329","author":"RP Shank","year":"1985","unstructured":"Shank RP, Bennett GS, Freytag SO, Campbell GL (1985) Pyruvate carboxylase: an astrocyte-specific enzyme implicated in the replenishment of amino acid neurotransmitter pools. Brain Res 329:364\u2013367","journal-title":"Brain Res"},{"key":"1678_CR94","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1111\/j.1471-4159.1983.tb00849.x","volume":"41","author":"AC Yu","year":"1983","unstructured":"Yu AC, Drejer J, Hertz L, Schousboe A (1983) Pyruvate carboxylase activity in primary cultures of astrocytes and neurons. J Neurochem 41:1484\u20131487","journal-title":"J Neurochem"},{"key":"1678_CR95","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1006\/abio.2000.4542","volume":"280","author":"CN Sarkissian","year":"2000","unstructured":"Sarkissian CN, Scriver CR, Mamer OA (2000) Measurement of phenyllactate, phenylacetate, and phenylpyruvate by negative ion chemical ionization\u2013gas chromatography\/mass spectrometry in brain of mouse genetic models of phenylketonuria and non-phenylketonuria hyperphenylalaninemia. Anal Biochem 280:242\u2013249","journal-title":"Anal Biochem"},{"issue":"Suppl 1","key":"1678_CR96","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/j.ymgme.2005.06.014","volume":"86","author":"AE Martynyuk","year":"2005","unstructured":"Martynyuk AE, Glushakov AV, Sumners C, Laipis PJ, Dennis DM, Seubert CN (2005) Impaired glutamatergic synaptic transmission in the PKU brain. Mol Genet Metab 86(Suppl 1):S34\u2013S42","journal-title":"Mol Genet Metab"},{"key":"1678_CR97","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/jnr.10569","volume":"72","author":"AV Glushakov","year":"2003","unstructured":"Glushakov AV, Dennis DM, Sumners C, Seubert CN, Martynyuk AE (2003) L-phenylalanine selectively depresses currents at glutamatergic excitatory synapses. J Neurosci Res 72:116\u2013124","journal-title":"J Neurosci Res"},{"key":"1678_CR98","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/brain\/awh354","volume":"128","author":"AV Glushakov","year":"2005","unstructured":"Glushakov AV, Glushakova O, Varshney M, Bajpai LK, Sumners C, Laipis PJ, Embury JE, Baker SP, Otero DH, Dennis DM, Seubert CN, Martynyuk AE (2005) Long-term changes in glutamatergic synaptic transmission in phenylketonuria. Brain 128:300\u2013307","journal-title":"Brain"},{"key":"1678_CR99","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/jnc.12683","volume":"129","author":"E Imperlini","year":"2014","unstructured":"Imperlini E, Orru S, Corbo C, Daniele A, Salvatore F (2014) Altered brain protein expression profiles are associated with molecular neurological dysfunction in the PKU mouse model. J Neurochem 129:1002\u20131012","journal-title":"J Neurochem"},{"key":"1678_CR100","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/jcbfm.1992.138","volume":"12","author":"JB Schulz","year":"1992","unstructured":"Schulz JB, Wree A, Schleicher A, Zilles K (1992) Plasticity in the rat hippocampal formation following ibotenic acid lesion of the septal region: a quantitative [14C]deoxyglucose and acetylcholinesterase study. J Cereb Blood Flow Metab 12:1007\u20131021","journal-title":"J Cereb Blood Flow Metab"},{"key":"1678_CR101","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00570304","volume":"88","author":"A Wree","year":"1988","unstructured":"Wree A, Schleicher A, Zilles K, Beck T (1988) Local cerebral glucose utilization in the Ammon\u2019s horn and dentate gyrus of the rat brain. Histochemistry 88:415\u2013426","journal-title":"Histochemistry"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-015-1678-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-015-1678-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-015-1678-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-015-1678-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T12:30:53Z","timestamp":1652963453000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-015-1678-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,30]]},"references-count":101,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["1678"],"URL":"https:\/\/doi.org\/10.1007\/s11064-015-1678-y","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,30]]},"assertion":[{"value":"23 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}